| Catalog_no |
ADMC1001 |
| Product_name |
LY2835219 free base (Abemaciclib) |
| Category |
抑制剂与激动剂 |
| Size |
10mg/50mg/100mg |
| Price |
1000.00/2120.00/2660.00 |
| Specificity |
TargetTargets the CDK4 (cyclin D1) and CDK6 (cyclin D3) cell cycle pathway, with potential antineoplastic activity. IC50: 2 nM (CDK4), 10 nM (CDK6) |
| Dilution |
IC50: 2 nM (CDK4), 10 nM (CDK6) |
| Purification |
>99% |
| Concentration |
靶点：CDK;IC50： 2 nM (CDK4), 10 nM (CDK6) |
| Storage_stability |
2 years -20°C Powder, 2 weeks4°C in DMSO,6 months-80°C in DMSO |
| othername |
LY2835219; LY-2835219; LY 2835219 |
| Molecular Weight |
506.6 |
| Notes |
LY2835219 is an orally available cyclin-dependent kinase (CDK) inhibitor that targets the CDK4 (cyclin D1) and CDK6 (cyclin D3) cell cycle pathway, with potential antineoplastic activity. IC50: 2 nM (CDK4), 10 nM (CDK6) |
| Instructions |
 查看与下载 |
